期刊文献+

抗核周因子滴度在类风湿性关节炎中的意义 被引量:1

The titer of APF in rheumatoid arthritis
下载PDF
导出
摘要 目的 探讨抗核周因子 (APF)滴度在类风湿性关节炎 (RA)中的临床意义。方法 间接免疫荧光法检测 1 4 3例RA患者血清中IgG型APF ,阳性血清作倍比稀释至其滴度为 1∶2 5 6 0。所得结果结合临床进行分析。结果 根据APF滴度将 97例APF阳性RA分为 4组 ,即 1∶1 0~ 1∶2 0组 6例 ,1∶4 0~ 1∶80组 1 8例 ,1∶1 6 0~ 1∶32 0组 5 2例 ,大于或等于 1∶6 4 0组 2 1例。压痛关节指数、肿胀关节指数、医生病情活动评价、患者病情活动评价、ESR、CRP、RF阳性率、RF平均滴度等随APF滴度增加而呈上升趋势 ;APF滴度与RF滴度呈正相关。结论 APF的滴度一定程度反应了RA病情的活动性 ,可能为RA预后不良的指标之一。 Aim To investigate the association between titer of antiperinuclear factor(APF) and the disease activity and severity of rheumatoid arthritis.Methods APF was measured with indirect immunofluorescence technique in 143 patients with RA, and all APF positive sera were diluted to 1∶ 2 560 .Based the titer of APF,the patients were divided into 4 groups(1∶10~1∶20, 1∶40~1∶80,1∶160~1∶ 320 ,1∶640~).The ESR,CRP,RF tender joint count and swollen joint count,patient's and physician's global assessment of disease activity,modified Sharp's radiological progression scores were compared between every groups.Results The patient's global assessment was significantly higher in the higher titer groups. Although no statistical significance can was obtained, the level and occurrence of RF, tender and swollen joint count, physician's global assessment of disease activity, and modified sharp's radiological progression scores were also higher in the higher titer groups; The titer of APF was correlated to the titer of RF (r=0 32,P=0 049 ). Conclusion The titer of APF might indicate the disease activity of RA and a bad prognosis.
作者 钱龙 曾庆馀
出处 《安徽医药》 CAS 2004年第4期260-261,共2页 Anhui Medical and Pharmaceutical Journal
关键词 滴度 RA 抗核周因子 APF 病情活动 类风湿性关节炎 患者 结论 生病 指数 antiperinuclear factor autoantibodies arthritis rheumatoid
  • 相关文献

参考文献7

  • 1钱龙,曾庆馀,黄少弼,肖征宇,许杰洲,谢素和.抗核周因子的检测及其在类风湿关节炎中的意义[J].中华风湿病学杂志,1999,3(2):100-103. 被引量:29
  • 2[2]Munoz-Femandez S, Alvarez-Doforno R,et al. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis [J]. J Rheumatoid, 1999,26:2572 - 7.
  • 3[3]Vittecoq O, Jouen-Beades F, Krzanowska K,et al. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis[J]. A preliminary study. Joint Bone Spine,2001,68:144 - 153.
  • 4[4]Munoz Fernandez S, Alvarez Diforno RA, Gijion J, et al. Relationship between antiperinuclear factor and inflammatory activity in rheumatoid arthritis [J]. Br J Rheumatol, 1994,53:282 - 3.
  • 5[5]Manera C, Franceschini F, Cretti L, et al. Clinical heterogeneity of rheumatoid and the antiperinuclear factor[J]. J Rheumatol, 1994,21:2021 -5.
  • 6[6]Kerstens PJ, Boerbooms AM, Jeurissen ME, et al. Antiperinuclear factor and activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy [J]. J Rheumatol,1994,21:2190 -4.
  • 7[7]Kurki P, yon Essen R, Kaarela K, et al. Antibody to stratum(antikeratin antibody) and antiperinuclear factor:marker for progressive rheumatoid arthritis[J]. Scand J Rheumatol, 1997,26:346 - 9.

共引文献28

同被引文献34

  • 1徐朝焰,赵素萍,吴美辉,林立人,余喜然.抗环瓜氨酸肽抗体对类风湿关节炎的诊断意义[J].中华风湿病学杂志,2005,9(11):700-701. 被引量:20
  • 2李光迪,刘芳,张长菊.抗环瓜氨酸肽抗体与类风湿因子IgM联合检测在类风湿关节炎早期诊断中的应用[J].国际检验医学杂志,2007,28(8):696-698. 被引量:9
  • 3Nienhuis RL,Mandema E.A new serum factor in patients with rheumatoid arthritis:the antiperinuclear factor [J].Ann Rheum Dis, 1964,23(2):302-303.
  • 4Liu RY, Wang KZ, Wang CS, et al. Evaluation of medial acetabular wall bone stock in patients with developmental dysplasia of the hip using a helical computed tomography multilane reconstruction technique[J]. Acta Radio,2009,50 (7):791-797.
  • 5Hassfeld W,Steiner G,Hartmuth K,et al.Demonstration of a new anti-nuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis[J].Arthritis Rheum,1989,32(12):1515-1520.
  • 6Steiner G,Hartmuth K,Skiner K,et al.Purification and partial se- quencing of the nuclear autoantigen RA33 shows that it is indistin- guishable from the A2 protein of the heterogeneous nuclear ri- bonueleoprotein eomplex[J].Clin Invest,1992, 90(3):1061-1066.
  • 7Steiner G, Smolen J.Autoantibodies in rheumatoid arthritis and their clinical significance[J].Arthritis Res,2002,4(Suppl2):S1-5.
  • 8Schellekens GA,Visser H,DeJong BAW,et al.The diagnostic prop-erties of rheumatoid arthritis antibodies recognizing a cyclic citrul- linated peptide[J]. Arthritis Rheum,2000,43(1):155-163.
  • 9Esalatmanesh K,Jamali R, Jamali A,et al.Serum anti-cyclic cit- rullinated peptide antibodies may predict disease activity in rheumatoid arthfitis[J].Rheumatol Int,2012,32(12):3799-3805.
  • 10Dejaco C,Duftner C,Klotz W,et al.Third generation anti-cyclic cit- mllinated peptido antibodies do not predict anti-TNF-alpha treat- ment response in rhoumatoid arthfitis[J].Rheumatol Int,2010,30(4): 451-454,.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部